🇺🇸 FDA
Patent

US 10752882

Compositions and methods for treating retinal diseases

granted A61KA61K35/30A61K9/0019

Quick answer

US patent 10752882 (Compositions and methods for treating retinal diseases) held by The Regents of the University of California expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/30, A61K9/0019, A61K9/0048, A61P